`
`Substitute for form 1449/PTO
`
`SECOND SUPPLEMENTAL
`
`INFORMATION DISCLOSURE
`
`Cam I lete i Known
`
`Application Number
`14/500,409
`
`Eouivalent Of Form PTO/SB/OBb 7-09
`
`
`ArtUnit
`STATEMENT BY APPLICANT
`1628
`
`(USE as many sheets as necessary)
`Examiner Name
`Ricci, Craig D.
`Attorney Docket Number
`1861.2700001/JMC/MSB
`
`NON PATENT LITERATURE DOCUMENTS
`
`Examiner
`Initials*
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog, etc.),
`date, page(s), volume-issue number(s), publisher, city and/or country Where published
`
` N
`
`
`DAS, N.G. and DAS, S.K., "Development of Mucoadhesive Dosage Forms of
`Buprenorphine for Sublingual Drug Delivery," Drug Delivery 11:89-95, Informa
`Healthcare, England (2004)
`
`
`
`1960192_1
`
`Examiner
`
`-_
`/Cra:g RECCI/
`Signature
`
`.
`
`:
`
`_
`
`,
`
`Date
`
`03/22/20l5
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance
`and not considered. Include copy of this form with next communication to applicant.
`1 Applicant’s unique citation designation number (optional). 2 Applicant is to place a check mark here if English language Translation is attached.
`ALL REFERENCES CONSIEERED EXCEPT WHERE LINES THRQUQH.
`
`/C.E./’
`
`